Author:
Dimitrios Farmakiotis, MD Jeffrey J. Tarrand, MD Dimitrios P. Kontoyiannis, MD, ScD, FIDSA
Full conference title:
IDWeek 2015 San Diego, CA
Date: 14 November 2017
Abstract:
Background. Central venous catheter (CVC) removal is beneficial in patients with CVC-related candidemia, defined as a higher colony count in a catheter lumen, compared to peripheral blood. However, clinicians are often faced with a blood culture growing Candida in a patient with a CVC, and few laboratories perform quantitative cultures. Therefore, it was proposed that short time-to-culture positivity (TTP) can be suggestive of catheter-related candidemia, in series of predominantly C. albicans candidemia episodes. Given the epidemiologic shift to non-albicans Candida species, and the longer time to detection for C. glabrata, compared to other Candida species, we studied the clinical characteristics of patients with CVC-related C. glabratafungemia and the diagnostic utility of time-to-reporting (TTR) of positive blood cultures.
Methods. We included patients with at least one blood culture(s) positive for C. glabrata, a CVC and available TTR, seen at MD Anderson Cancer Center between March 2005 and September 2013. CVC-related candidemia was defined as a colony count in a blood culture obtained via the CVC at least fivefold greater than the colony count in peripheral blood.
Results. Fifty-six of 119 patients studied (49%) were deemed to have CVC-related candidemia. Those patients were less likely to be on total parenteral nutrition (TPN, 34 [42%] versus 48 [59%] of those with non-CVC-related candidemia, P = 0.01), or have an absolute neutrophil count <100/μL (2 [4%] versus 13 [22%], P < 0.01). TTR was shorter in patients with CVC-related candidemia (mean ± standard deviation, 67 ± 35 hours) compared to those with non-CVC-related candidemia (79 ± 31 hours, P < 0.01), and had significant diagnostic value by ROC analysis (figure). A TTR <48 hours was 99% specific for CVC-related candidemia.
Conclusion. Among patients with C. glabrata fungemia, an abdominal source was more likely than CVC-related candidemia in severely neutropenic patients and in those receiving TPN. In the evaluation of patients with C. glabrata fungemia, a TTR of <48 hours could further support the decision to remove the CVC.
Disclosures. All authors: No reported disclosures.
Conference Year: 2015
Link to conference website: IDWeek 2015
Tables:
Link Conference abstract:
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
J Furlong-Silva1*, G Vere1, BM Invergo2, AR Jeffries2, G Brown1, E Bignell1, PC Cook1
2022
73
n/a
-
v
BN Steffan1*, DG Calise1, NP Keller1,2
2022
72
-
v
R Hamashima1,2*, M Tashiro1,3, Y Nakano1, N Ashizawa4, K Takeda4, N Iwanaga4, K Nishi5, A Fujita3, T Takazono1,4, T Tanaka3, K Yamamoto4, H Liu9, Y Komohara8, A Furumoto6, K Yanagihara7, H Mukae4, SG Filler9, K Takayama2, K Izumikawa1,3
2022
71
-
v
S Grau1, S Hartung1,2, Z Cseresnyés3, M Hoang1,2, K Rennert4, AS Mosig5,6, MT Figge3,7, M von Lilienfeld-Toal1,2, S Jahreis1,2*
2022
70
-
v
U Binder1*, MI Navarro-Mendoza2, FE Nicolas2, C Kandelbauer1, R Pföstl1, I Bauer3, C Lass-Flörl1, V Garre2
2022
69
-
v
T Arai1*, H Takahashi1, Y Kusuya1, H Majima1,2, A Watanabe1, K Kamei1
2022
68
-
v
BS Ross1*, LA Lofgren2, A Ashare3, JE Stajich2, RA Cramer1
2022
67
-
v
U Perez-Cuesta1*, X Guruceaga2, S Cendon-Sanchez 1, E Pelegri-Martinez 1, A Prieto-Fiel1, I Buldain1, A Antoran1, A Ramirez-Garcia1, A Abad-Diaz-de-Cerio1, A Rementeria1
2022
66
-
v
TF Furukawa1*, NvR van Rhijn1, JR Rhodes2, RFG Fortune-Grant1, EB Bignell1, MF Fisher2, MB Bromley1
2022
65
-
v
AA Kelani1, A Bruch1, C Visser2, AA Brakhage2, MG Blango1*
2022
64